Potassium Chloride
Severe
Database
Drug interaction classified as: absorption
Source: DDInter
Drug reference
clidinium
Semisynthetic anticholinergic, Quaternary compound · Antispasmodic, Antisecretory
Semisynthetic anticholinergic, Quaternary compoundAntispasmodic, Antisecretory
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
4 major
SEVERE in our sources
PREGNANCY
—
not curated
Top interactions
- Potassium ChlorideSevereDatabaseDDInter
- Potassium CitrateSevereDatabaseDDInter
- TopiramateSevereDatabaseDDInter
- ZonisamideSevereDatabaseDDInter
Mechanism
Clidinium is an antisecretory-antispasmodic anticholinergic drug. It is typically used in combination with benzodiazepines.
Indications
Nervous dyspepsia (in combination with benzodiazepines)Gastritis (in combination with benzodiazepines)Irritable bowel syndrome (in combination with benzodiazepines)Colic (in combination with benzodiazepines)Peptic ulcer (in combination with benzodiazepines)
Dosing
- Adult
- 2.5–5 mg oral
Drug interactions
Potassium Citrate
Severe
Database
Clinical effect not specified
Source: DDInter
Topiramate
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Zonisamide
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
8 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.
Related guidelines
Irritable bowel syndrome
ISG · Gastroenterology · 2023
Preventive care in inflammatory bowel disease
ACG · Gastroenterology · 2025
Empirical antimicrobial use in common syndromes
ICMR · Infectious Diseases · 2019
Inflammatory bowel disease
OTHER · Gastroenterology · 2015
Gastric premalignant conditions
ACG · Gastroenterology · 2025
Other Semisynthetic anticholinergic, Quaternary compound drugs
Ask House about clidinium
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team